Trials / Completed
CompletedNCT05672745
How Phenotypical Characteristics of Woebot Users Are Related to Clinical Outcomes
An Open-label Pilot Study to Learn How the Phenotypical Characteristics of Woebot Users Are Related to Clinical Outcomes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 256 (actual)
- Sponsor
- Woebot Health · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this observational study is to understand the characteristics of Woebot users as they relate to clinical outcomes. The objectives it aims to address are: 1. To assess Woebot usage patterns, satisfaction ratings, self-efficacy, stress, resilience, work productivity and activity impairment, alexthymia, and bond over time based on demographic, clinical baseline levels, and attitudinal characteristics 2. Among users who present with clinical levels of anxiety or depression, to assess the contribution of demographic characteristics, attitudinal characteristics, and patterns of engagement on clinical outcomes of interest over time 3. To collect and explore attitudinal characteristics of Woebot users regarding their experiences with mental health care and perceived value of digital tools for emotional support 4. Explore meaningful subgroups of Woebot users based on demographic and attitudinal characteristics, clinical outcomes, and patterns of engagement Participants who meet study eligibility requirements will be: * invited to engage with the Woebot Life program for 8 weeks * complete survey assessments at day 3, week 4 (mid-intervention), and week 8 (end of intervention)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | WB-LIFE | WB-LIFE is a mobile application program grounded in validated psychotherapies (including cognitive behavioral therapy, interpersonal, and dialectical behavioral therapy), that enlists the relational agent Woebot to guide users in managing their mood. The user experience is driven by artificial intelligence and centers around mood tracking, evidence-based tools, and goal-oriented, tailored conversations. |
Timeline
- Start date
- 2022-05-11
- Primary completion
- 2022-07-23
- Completion
- 2022-07-23
- First posted
- 2023-01-05
- Last updated
- 2023-01-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05672745. Inclusion in this directory is not an endorsement.